Schacker, T <br/><br/>
Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial.  [electronic resource] 

 -  Annals of internal medicine  Jan 1998 
 - 21-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0003-4819 
<br/><br/><label>Standard No.: </label>10.7326/0003-4819-128-1-199801010-00004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Aminopurine--analogs & derivatives<br/>AIDS-Related Opportunistic Infections--drug therapy<br/>Adult<br/>Aged<br/>Antibodies, Viral--blood<br/>Antiviral Agents--therapeutic use<br/>CD4 Lymphocyte Count<br/>Cross-Over Studies<br/>Double-Blind Method<br/>Famciclovir<br/>Female<br/>Herpes Simplex--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Proportional Hazards Models<br/>Regression Analysis<br/>Simplexvirus--growth & development<br/>Virus Activation<br/>Virus Shedding